LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 807 | 4513 | 0.1788 | -0.1309 |
MDA-MB-231 | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4560 | 4513 | 1.0104 | 1.0143 |
MDA-MB-231 | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4685 | 4513 | 1.0380 | 1.0523 |
MDA-MB-231 | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4266 | 4513 | 0.9453 | 0.9247 |
MDA-MB-231 | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4266 | 4513 | 0.9452 | 0.9246 |
MDA-MB-231 | R406 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4461 | 4513 | 0.9884 | 0.9840 |
MDA-MB-231 | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3867 | 4513 | 0.8567 | 0.8027 |
MDA-MB-231 | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4483 | 4513 | 0.9934 | 0.9909 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2583 | 4513 | 0.5723 | 0.4111 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1876 | 4513 | 0.4157 | 0.1954 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4766 | 4513 | 1.0559 | 1.0770 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3977 | 4513 | 0.8811 | 0.8363 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3957 | 4513 | 0.8768 | 0.8303 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2003 | 4513 | 0.4438 | 0.2341 |
MDA-MB-231 | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4161 | 4513 | 0.9219 | 0.8924 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4047 | 4513 | 0.8968 | 0.8578 |
MDA-MB-231 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4740 | 4513 | 1.0501 | 1.0691 |
MDA-MB-231 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4028 | 4513 | 0.8925 | 0.8519 |
MDA-MB-231 | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4316 | 4513 | 0.9564 | 0.9399 |
MDA-MB-231 | JNK-9L | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3882 | 4513 | 0.8601 | 0.8074 |
MDA-MB-231 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4157 | 4513 | 0.9210 | 0.8912 |
MDA-MB-231 | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3964 | 4513 | 0.8784 | 0.8325 |
MDA-MB-231 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4445 | 4513 | 0.9849 | 0.9792 |
MDA-MB-231 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4674 | 4513 | 1.0356 | 1.0490 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3774 | 4513 | 0.8362 | 0.7744 |